A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

After BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...

Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

Messenger RNA (mRNA) is a subtype of RNA. An mRNA molecule carries a portion of the DNA code to other parts of the cell for processing. mRNA is created during transcription.

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is ...